218 related articles for article (PubMed ID: 8096389)
1. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
Holdright DR; Katz RJ; Wright CA; Sparrow JL; Sullivan AK; Cunningham AD; Fox KM
Br Heart J; 1993 Mar; 69(3):223-7. PubMed ID: 8096389
[TBL] [Abstract][Full Text] [Related]
2. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
Fox KM; Dargie HJ; Deanfield J; Maseri A
Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152
[TBL] [Abstract][Full Text] [Related]
3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
4. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
Nyberg G
Br Heart J; 1993 Nov; 70(5):486. PubMed ID: 7903150
[No Abstract] [Full Text] [Related]
5. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
Whalley DW; Hellestrand KJ
Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
[TBL] [Abstract][Full Text] [Related]
7. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Freedman SB; Daxini BV; Noyce D; Kelly DT
J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
[TBL] [Abstract][Full Text] [Related]
8. An acute double-blind placebo-controlled study of transdermal glyceryl trinitrate with 12 months' follow-up in patients with stable angina pectoris.
Heepe W
J Int Med Res; 1987; 15(4):198-204. PubMed ID: 3115846
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
James MA; Walker PR; Papouchado M; Wilkinson PR
Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
[TBL] [Abstract][Full Text] [Related]
10. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
DeMots H; Glasser SP
J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
[TBL] [Abstract][Full Text] [Related]
11. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
Akhras F; Hellestrand K; Whalley D; Jackson G
Int J Cardiol; 1994 Mar; 43(3):251-6. PubMed ID: 8181883
[TBL] [Abstract][Full Text] [Related]
13. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Bonelli J; Gazo F; Liedtke RK
Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.
Scardi S; Camerini F; Pandullo C; Pollavini G
Int J Cardiol; 1991 Aug; 32(2):241-8. PubMed ID: 1917174
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
16. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
[TBL] [Abstract][Full Text] [Related]
17. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
Luke R; Sharpe N; Coxon R
J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
[TBL] [Abstract][Full Text] [Related]
18. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
Schaer DH; Buff LA; Katz RJ
Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
[TBL] [Abstract][Full Text] [Related]
20. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.
Sullivan M; Savvides M; Abouantoun S; Madsen EB; Froelicher V
J Am Coll Cardiol; 1985 May; 5(5):1220-3. PubMed ID: 3921585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
